DFTX Reports Positive Phase 3 Results
Definium Therapeutics announces positive topline results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet in Major Depressive Disorder
DFTX Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder